$5.58
0.050.94%
Pre-Market: 4:54 PM EDT
Comments
Loading...
Cara Therapeutics Stock Guidance | NASDAQ:CARA | Benzinga
Cara Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cara Therapeutics Inc (CARA) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Cara Therapeutics (CARA)?
There have been no specific sales or earnings guidance reported for Cara Therapeutics in recent months.
Browse guidance and forecast on all stocks.